Drug Profile
Tilnoprofen arbamel
Alternative Names: Y 23023Latest Information Update: 11 Mar 1996
Price :
$50
*
At a glance
- Originator Mitsubishi Pharma Corporation
- Developer Japan Tobacco; Mitsubishi Pharma Corporation
- Class Antirheumatics; Nonsteroidal anti-inflammatories; Opioid analgesics
- Mechanism of Action Cyclooxygenase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Pain; Rheumatoid arthritis
Most Recent Events
- 11 Mar 1996 Discontinued-III for Pain in Japan (PO)
- 11 Mar 1996 Discontinued-III for Rheumatoid arthritis in Japan (PO)